Cetera Investment Advisers
PLSE icon

Cetera Investment Advisers’s Pulse Biosciences PLSE Stock Holding History

Cetera Investment Advisers’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$387K Buy
+17,928
New +$331K ﹤0.01% 3747
2024
Q2 		– Sell
-13,370
Closed -$116K – 3825
2024
Q1 		$116K Buy
+13,370
New +$123K ﹤0.01% 3469

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Cetera Investment Advisers's PLSE Position: Q1 2026 in Review

Cetera Investment Advisers opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 17,928 shares worth $387K. The stake represents ﹤0.01% of the portfolio and ranks #3747 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in PLSE as recently as Q1 2024.

Cetera Investment Advisers first reported a position in PLSE in Q1 2024 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Cetera Investment Advisers held 17,928 shares of Pulse Biosciences worth $387K as of Q1 2026.
  • Pulse Biosciences was a new Cetera Investment Advisers position in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3747 holding.
  • Cetera Investment Advisers first reported a position in Pulse Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.